BioSpace News Archive

Drug Development

Abstract Describing Use of Oregovomab in Pancreatic Cancer to be Published in JCO as Part of ASCO 2018 Meeting

OncoQuest Inc. announced the publication of an abstract, titled “A Phase II Study of Neoadjuvant Chemoimmunotherapy Followed by Stereotactic Radiotherapy/Nelfinavir in Patients with Locally Advanced CA125 Expressing Pancreatic Adenocarcinoma” in the Journal of Clinical Oncology 36, 2018.

June 1, 2018
·
4 min read
Mylan to Present at Goldman Sachs 39th Annual Global Healthcare Conference

CEO Heather Bresch will present at the Goldman Sachs 39th Annual Global Healthcare Conference in Rancho Palos Verdes, CA, on Wednesday, June 13, 2018, at 1:20 p.m. PT / 4:20 p.m. ET.

June 1, 2018
·
1 min read
Genetown

Enanta Pharmaceuticals to Present at the NASDAQ 38th Investor Conference Presentation to be Webcast on June 12 at 9:30 A.M. GMT

Enanta Pharmaceuticals, Inc. announced that Jay R. Luly, President and Chief Executive Officer will make a presentation followed by a question and answer session at the NASDAQ 38th Investor Conference.

June 1, 2018
·
1 min read
Pharm Country

PAVmed Updates the Terms of Previously Announced Rights Offering

Each right now entitles the holder to purchase one unit at the subscription price of $1.15 per unit and each unit remains comprised of one share of the Company’s common stock and one Series Z Warrant.

June 1, 2018
·
4 min read
Pharm Country

Pfizer Receives Positive CHMP Opinion for Oncology Biosimilar, TRAZIMERA™ (trastuzumab)

TRAZIMERA, a potential biosimilar to Herceptin® (trastuzumab), is Pfizer’s first therapeutic oncology biosimilar to undergo regulatory review in Europe

June 1, 2018
·
7 min read
Business

BD Names John DeFord Chief Technology Officer

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today appointed John A. DeFord as executive vice president and chief technology officer.

June 1, 2018
·
2 min read
Pharm Country

CHMP Adopts Positive Opinion for the Expansion of the Translarna™ (ataluren) Label to Include Patients as Young as 2 Years of Age

European Commission ratification anticipated in coming months

June 1, 2018
·
6 min read
Pharm Country

BrainStorm to Host Call Following President Trump’s Citing of Company’s ALS Treatment During “Right-to-Try” Bill Signing

BrainStorm Cell Therapeutics Inc. announced today that the company will host a “Right-to-Try” (RTT) discussion call on Thursday, June 7th at 8:15am EDT.

June 1, 2018
·
6 min read
Bio NC

Pedicures & Better Cures: Blue Ridge Orthodontics Donating All Profits from Their Spa Services to Mission Children’s Hospital

Blue Ridge Orthodontics (BRO) is happy to announce that they will be donating 100% of the profits from their in-house spa services to Mission Children’s Hospital.

June 1, 2018
·
3 min read
Menarini Ricerche to Present the Study Design of CD205-Shuttle, a First-in-human Trial of MEN1309/OBT076, at the ASCO Annual Meeting 2018

Menarini Ricerche (Menarini Group) will present at ASCO Annual Meeting 2018 the study design of CD205-Shuttle.

June 1, 2018
·
2 min read